A Note From Gary
I’m writing to you as a person with diabetes or a loved one who I know is concerned with making sure that new diabetes technology is approved, covered and utilized to their fullest capacity by the most people.
Events: Back to School Advocacy Webinar for Parents of Children with Diabetes
Back to School Advocacy Webinar for Parents of Children with Diabetes You will hear from parents and advocates who have been there - on behalf of their own children and through their work with other parents who want to keep their children safe at school!
July’s Survey – “Hybrid Closed Loop” Systems
View the results of last month's survey and VOTE a new July survey!
Practical CGM – by Gary Scheiner
An invaluable source for people with diabetes as well as the diabetes experts who care for them. Use of real-time continuous glucose monitors among people with type 1 and type 2 diabetes is growing rapidly and should continue to grow until an artificial pancreas is brought to market.
Eversense 90 day implantable CGM approved in Europe
A company called Senseonics has announced that its Eversense Continuous Glucose Monitor (CGM) received CE Mark approval in Europe. It will launch is Sweden in June and in Norway and Denmark by the end of the year.
Working towards a stable liquid glucagon
When new drugs hit the market, lots of research has been done to evaluate their safety and effectiveness. When you hear about drugs that are in development and the results of research that is being done, you are often hearing about phase III clinical trial results.
Studying outliers could lead to new therapy targets for Type 1 diabetes
The Leona M. and Harry B. Helmsley Charitable Trust has a Type 1 Diabetes Program, and in May they announced $1.4 million in grants to support the study of unusual clinical cases of Type 1 Diabetes (T1D).
Improving A1c may help bone health in type 1 diabetes
Some encouraging research was presented at the European Congress of Endocrinology meeting in May of this year. It showed that improving the A1c seems to ease loss of bone mineral density (BMD)and bone turnover in people with type 1 diabetes.
Will LEADER change the way we treat diabetes?
The results of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial of the glucose-lowering drug liraglutide
Nutrition to control diabetes
Do you need a nutrition makeover? If you have diabetes, you need to manage your weight, blood glucose (BG), blood pressure (BP), and cholesterol levels. Food choices can help us to do this.